Asiatic Laboratories Limited (DSE:ASIATICLAB)
Bangladesh · Delayed Price · Currency is BDT 104.20
+2.50 (2.46%)
At close: Nov 4, 2026
Asiatic Laboratories Revenue
Asiatic Laboratories had revenue of 788.96M BDT in the quarter ending March 31, 2026, with 145.10% growth. This brings the company's total for the last twelve months to 2.90B, up 109.71% year-over-year. In the fiscal year ending June 30, 2025, Asiatic Laboratories had annual revenue of 1.77B with 27.45% growth. That makes Asiatic Laboratories the 32,879th largest company in the world by revenue and 119th in Bangladesh.
Revenue (ttm)
2.90B
Revenue Growth
+109.71%
P/S Ratio
4.39
Revenue / Employee
3.94M
Employees
737
Market Cap
12.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.77B | 380.24M | 27.45% |
| Jun 30, 2024 | 1.39B | 95.98M | 7.44% |
| Jun 30, 2023 | 1.29B | -183.53M | -12.46% |
| Jun 30, 2022 | 1.47B | 21.53M | 1.48% |
| Jun 30, 2021 | 1.45B | 124.89M | 9.42% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Beximco Pharmaceuticals PLC. | 53.93B |
| Renata | 46.20B |
| The ACME Laboratories | 40.05B |
| Beacon Pharmaceuticals | 15.57B |
| The IBN SINA Pharmaceutical Industry | 13.90B |
| Navana Pharmaceuticals | 10.57B |
| Unilever Consumer Care | 3.29B |
| Techno Drugs | 3.10B |